Chem. Commun., 2019, Advance Article
DOI: 10.1039/C9CC00163H, Communication
DOI: 10.1039/C9CC00163H, Communication
Bosheng Zhao, Kevin Burgess
PROTACs based on two selective, FDA approved, CDK4/6 inhibitors were formed. These PROTACs at nanomolar concentrations deplete CDK4/6.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
PROTACs based on two selective, FDA approved, CDK4/6 inhibitors were formed. These PROTACs at nanomolar concentrations deplete CDK4/6.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
from Journals via hj on Inoreader https://rsc.li/2SReQMA
No comments:
Post a Comment